Perioperative anemia management in colorectal cancer patients: A pragmatic approach

World Journal of Gastroenterology

Volumn 20, Issue 8, 2014, Pages 1972-1985

  Muñoz, Manuel ^a   Gómez Ramírez, Susana ^b   Martín Montañez, Elisa ^a   Auerbach, Michael ^c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic blood transfusion; Anemia; Colorectal cancer; Erythropoiesis stimulating agents; Intravenous iron; Patient Blood Management

Indexed keywords

ERYTHROPOIETIN; IRON; OXYGEN;

ADVERSE EFFECTS; ALGORITHM; ANEMIA; BLOOD TRANSFUSION; CHEMISTRY; COLORECTAL NEOPLASMS; COMPLICATION; EUROPE; FEMALE; HUMAN; MALE; PERIOPERATIVE PERIOD; QUALITY OF LIFE;

ALGORITHMS; ANEMIA; BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; ERYTHROPOIETIN; EUROPE; FEMALE; HUMANS; IRON; MALE; OXYGEN; PERIOPERATIVE CARE; PERIOPERATIVE PERIOD; QUALITY OF LIFE;

EID: 84894599526     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i8.1972     Document Type: Article

References (102)

1. Cappell MS, Goldberg ES. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients. A significant trend of earlier cancer detection from 1982 through 1988 at a university hospital. J Clin Gastroenterol 1992; 14: 227-235 [PMID: 1564298]
2. Sadahiro S, Suzuki T, Tokunaga N, Mukai M, Tajima T, Makuuchi H, Saito T. Anemia in patients with colorectal cancer. J Gastroenterol 1998; 33: 488-494 [PMID: 9719230]
3. Ludwig H, Van Belle S, Barrett-Lee P, Birgegård G, Bokemeyer C, Gascón P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004; 40: 2293-2306 [PMID: 15454256 DOI: 10.1016/j.ejca.2004.06.019]
4. Beale AL, Penney MD, Allison MC. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis 2005; 7: 398-402 [PMID: 15932566 DOI: 10.1111/j.1463-1318.2005.00789.x]
5. Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipancic I, Zarkovic N. Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett 2006; 238: 188-196 [PMID: 16111806 DOI: 10.1016/ j.canlet.2005.07.001]
6. Kim J, Konyalian V, Huynh R, Mittal R, Stamos M, Kumar R. Identification of predictive factors for perioperative blood transfusion in colorectal resection patients. Int J Colorectal Dis 2007; 22: 1493-1497 [PMID: 17768632 DOI: 10.1007/ s00384-007-0347-2]
7. Edna TH, Karlsen V, Jullumstrø E, Lydersen S. Prevalence of anaemia at diagnosis of colorectal cancer: assessment of associated risk factors. Hepatogastroenterology 2012; 59: 713-716 [PMID: 22469713 DOI: 10.5754/hge11479]
8. Ludwig H, Müldür E, Endler G, Hübl W. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol 2013; 24: 1886-1892 [PMID: 23567147 DOI: 10.1093/annonc/ mdt118]
9. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116 Suppl 7A: 58S-69S [PMID: 15050887 DOI: 10.1016/j.amjmed.2003.12.013]
10. Nilsson KR, Berenholtz SM, Dorman T, Garrett E, Lipsett P, Kaufman HS, Pronovost PJ. Preoperative predictors of blood transfusion in colorectal cancer surgery. J Gastrointest Surg 2002; 6: 753-762 [PMID: 12399066]
11. Benoist S. [Perioperative transfusion in colorectal surgery]. Ann Chir 2005; 130: 365-373 [PMID: 16023458 DOI: 10.1016/ j.anchir.2004.12.013]
12. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-1407 [PMID: 21982521 DOI: 10.1016/ S0140-6736(11)61381-0]
13. Kang CY, Chaudhry OO, Halabi WJ, Nguyen V, Carmichael JC, Stamos MJ, Mills S. Outcomes of laparoscopic colorectal surgery: data from the Nationwide Inpatient Sample 2009. Am J Surg 2012; 204: 952-957 [PMID: 23122910 DOI: 10.1016/ j.amjsurg.2012.07.031]
14. Zhen L, Zhe S, Zhenning W, Zhifeng M, Zhidong L, Xiaoxia L, Jianguang Y, Huimian X. Iron-deficiency anemia: a predictor of diminished disease-free survival of T3N0M0 stage colon cancer. J Surg Oncol 2012; 105: 371-375 [PMID: 21761412 DOI: 10.1002/jso.22032]
15. Fjørtoft I, Furnes B, Hausken T, Storli KE, Eide GE, Søndenaa K. Pre-operative anaemia in colon cancer patients became normal after more than a year post-operatively but did not influence oncological outcome in the final analysis. Scand J Gastroenterol 2013; 48: 663-671 [PMID: 23534433 DOI: 10.3109/00365521.2013.781216]
16. Harju E. Empty iron stores as a significant risk factor in abdominal surgery. JPEN J Parenter Enteral Nutr 1988; 12: 282-285 [PMID: 3392823]
17. Zago L, Dupraz H, Torino F, Río ME. [Preoperative nutritional status and surgical risk. Identification of promissory biochemical markers]. Nutr Hosp 2010; 25: 91-98 [PMID: 20204262]
18. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023 [PMID: 15758012 DOI: 10.1056/ NEJMra041809]
19. Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J Gastroenterol 2009; 15: 4617-4626 [PMID: 19787824]
20. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol 2011; 64: 281-286 [PMID: 21177266 DOI: 10.1136/ jcp.2010.079046]
21. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009; 113: 5277-5286 [PMID: 19293425 DOI: 10.1182/ blood-2008-12-195651]
22. Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ, Rowland KM, Novotny PJ, Loprinzi CL. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol 2011; 29: 97-105 [PMID: 21098317 DOI: 10.1200/JCO.2010.30.3644]
23. Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013; 88: 97-101 [PMID: 23335357 DOI: 10.1002/ajh.23354]
24. Ward DG, Roberts K, Brookes MJ, Joy H, Martin A, Ismail T, Spychal R, Iqbal T, Tselepis C. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol 2008; 14: 1339-1345 [PMID: 18322945]
25. Muñoz M, García-Erce JA, Díez-Lobo AI, Campos A, Sebastianes C, Bisbe E. [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. Med Clin (Barc) 2009; 132: 303-306 [PMID: 19264195 DOI: 10.1016/j.medcli.2008.04.011]
26. Liu K, Kaffes AJ. Iron deficiency anaemia: a review of diagnosis, investigation and management. Eur J Gastroenterol Hepatol 2012; 24: 109-116 [PMID: 22157204 DOI: 10.1097/ MEG.0b013e32834f3140]
27. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604 [PMID: 18372258 DOI: 10.1093/ bja/aen054]
28. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22 [PMID: 21148637 DOI: 10.1093/bja/aeq361]
29. Bermejo F, García-López S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol 2009; 15: 4638-4643 [PMID: 19787826]
30. Muñoz M, Botella-Romero F, Gómez-Ramírez S, Campos A, García-Erce JA. Iron deficiency and anaemia in bariatric surgical patients: causes, diagnosis and proper management. Nutr Hosp 2009; 24: 640-654 [PMID: 20049366]
31. Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15: 4666-4674 [PMID: 19787830]
32. Muñoz M, García-Erce JA, Remacha ÁF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol 2011; 64: 287-296 [PMID: 21177268 DOI: 10.1136/ jcp.2010.086991]
33. Reinisch W, Staun M, Bhandari S, Muñoz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis 2013; 7: 429-440 [PMID: 22917870 DOI: 10.1016/ j.crohns.2012.07.031]
34. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005; 18: 319-332 [PMID: 15737893 DOI: 10.1016/j.beha.2004.08.022]
35. Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013; 161: 639-648 [PMID: 23573815 DOI: 10.1111/bjh.12311]
36. Koch M, Antolovic D, Reissfelder C, Rahbari NN, Holoch J, Michalski I, Sweiti H, Ulrich A, Büchler MW, Weitz J. Leucocyte-depleted blood transfusion is an independent predictor of surgical morbidity in patients undergoing elective colon cancer surgery-a single-center analysis of 531 patients. Ann Surg Oncol 2011; 18: 1404-1411 [PMID: 21153884 DOI: 10.1245/s10434-010-1453-x]
37. Mortensen FV, Jensen LS, Sørensen HT, Pedersen L. Causespecific mortality associated with leukoreduced, buffy coatdepleted, or no blood transfusion after elective surgery for colorectal cancer: a posttrial 15-year follow-up study. Transfusion 2011; 51: 259-263 [PMID: 20804531 DOI: 10.1111/ j.1537-2995.2010.02825.x]
38. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006; (1): CD005033 [PMID: 16437512 DOI: 10.1002/14651858.CD005033.pub2]
39. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012; 256: 235-244 [PMID: 22791100 DOI: 10.1097/SLA.0b013e31825b35d5]
40. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, Rao SV, Roback JD, Shander A, Tobian AA, Weinstein R, Swinton McLaughlin LG, Djulbegovic B. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 2012; 157: 49-58 [PMID: 22751760 DOI: 10.7326/0003-4819-157-1-201206190-00429]
41. Leal-Noval SR, Muñoz M, Asuero M, Contreras E, García-Erce JA, Llau JV, Moral V, Páramo JA, Quintana M. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus 2013; 11: 585-610 [PMID: 23867181 DOI: 10.2450/2013.0029-13]
42. Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ. Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg 2007; 142: 126-132; discussion 133 [PMID: 17309963 DOI: 10.1001/archsurg.142.2.126]
43. Xenos ES, Vargas HD, Davenport DL. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res 2012; 129: 568-572 [PMID: 21872295 DOI: 10.1016/j.thromres.2011.07.047]
44. Davenport DL, Vargas HD, Kasten MW, Xenos ES. Timing and perioperative risk factors for in-hospital and postdischarge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb Hemost 2012; 18: 569-575 [PMID: 22345485 DOI: 10.1177/1076029611433642]
45. Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, McNaught CE, Macfie J, Liberman AS, Soop M, Hill A, Kennedy RH, Lobo DN, Fearon K, Ljungqvist O. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(®) Society recommendations. World J Surg 2013; 37: 259-284 [PMID: 23052794 DOI: 10.1007/s00268-012-1772-0]
46. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today 2005; 35: 36-40 [PMID: 15622462 DOI: 10.1007/ s00595-004-2888-0]
47. Lidder PG, Sanders G, Whitehead E, Douie WJ, Mellor N, Lewis SJ, Hosie KB. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery-a prospective, randomised, controlled trial. Ann R Coll Surg Engl 2007; 89: 418-421 [PMID: 17535624 DOI: 10.1308/003588407X1833 64]
48. Quinn M, Drummond RJ, Ross F, Murray J, Murphy J, Macdonald A. Short course pre-operative ferrous sulphate supplementation--is it worthwhile in patients with colorectal cancer? Ann R Coll Surg Engl 2010; 92: 569-572 [PMID: 20573311 DOI: 10.1308/003588410X12699663904277]
49. Ferrari P, Nicolini A, Manca ML, Rossi G, Anselmi L, Conte M, Carpi A, Bonino F. Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate. Biomed Pharmacother 2012; 66: 414-418 [PMID: 22795809 DOI: 10.1016/j.biopha.2012.06.003]
50. Muñoz M, Campos A, Garcia Erce JA. Intravenous iron in colorrectal cancer surgery. Semin Hematol 2006; 43 Suppl 6: S36-S38 [DOI: 10.1053/j.seminhematol.2013.06.008]
51. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007; 369: 1502-1504 [PMID: 17482969 DOI: 10.1016/S0140-6736(07)60689-8]
52. Muñoz M, Breymann C, García-Erce JA, Gómez-Ramírez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94: 172-183 [PMID: 18069918 DOI: 10.1111/j.1423-0410.2007.01014.x]
53. Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program 2010; 2010: 338-347 [PMID: 21239816 DOI: 10.1182/asheducation-2010.1.338]
54. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Pavía J, Cuenca J, García-Erce JA. Perioperative intravenous iron: an upfront therapy for treating anaemia and reducing transfusion requirements. Nutr Hosp 2012; 27: 1817-1836 [PMID: 23588429 DOI: 10.3305/nh.2012.27.6.6087]
55. Aapro M, Österborg A, Gascón P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol 2012; 23: 1954-1962 [PMID: 22575608 DOI: 10.1093/annonc/ mds112]
56. Kim YT, Kim SW, Yoon BS, Cho HJ, Nahm EJ, Kim SH, Kim JH, Kim JW. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 2007; 105: 199-204 [PMID: 17234260]
57. Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br J Surg 2009; 96: 1122-1128 [PMID: 19731228 DOI: 10.1002/bjs.6688]
58. Dangsuwan P, Manchana T. Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol 2010; 116: 522-525 [PMID: 20051288 DOI: 10.1016/j.ygyno.2009.12.004]
59. Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N. Clinical experience with ferric carboxymaltose in the treatment of cancer-and chemotherapy-associated anaemia. Ann Oncol 2013; 24: 475-482 [PMID: 23071262 DOI: 10.1093/annonc/mds338]
60. Athibovonsuk P, Manchana T, Sirisabya N. Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecol Oncol 2013; 131: 679-682 [PMID: 24099839 DOI: 10.1016/j.ygyno.2013.09.028]
61. Campos A, Sevilla I, Baca JJ, Romero A, Ramírez G, Muñoz M. Perioperative iron therapy and transfusion requirements in patients undergoing surgery for colon cancer. Preliminary results [abstract]. Transfus Altern Transfus Med 2005; 8 Suppl 1: 96
62. Díaz Espallardo C, Laso Morales MJ, Colilles Calvet C, Mora López L, Roig Martínez I, Martínez Marín MT. [The multidisciplinary approach is useful for optimising preoperative haemoglobin in colorectal cancer surgery]. Cir Esp 2011; 89: 392-399 [PMID: 21453911 DOI: 10.1016/ j.ciresp.2011.01.013]
63. Titos-Arcos JC, Soria-Aledo V, Carrillo-Alcaraz A, Ventura-López M, Palacios-Muñoz S, Pellicer-Franco E. Is intravenous iron useful for reducing transfusions in surgically treated colorectal cancer patients? World J Surg 2012; 36: 1893-1897 [PMID: 22552496 DOI: 10.1007/s00268-012-1589-x]
64. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107: 477-478 [PMID: 21841061 DOI: 10.1093/bja/aer242]
65. Fishbane S, Kowalski EA, Imbriano LJ, Maesaka JK. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996; 7: 2654-2657 [PMID: 8989744]
66. Auerbach M, Winchester J, Wahab A, Richards K, McGinley M, Hall F, Anderson J, Briefel G. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients. Am J Kidney Dis 1998; 31: 81-86 [PMID: 9428456 DOI: 10.1053/ajkd.1998.v31.pm9428456]
67. Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, Balan S, Barker L, Rana J. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 2004; 22: 1301-1307 [PMID: 15051778 DOI: 10.1200/JCO.2004.08.119]
68. Todman E, Mudan S, Rao Baikady R. Total dose iron infusion for iron deficiency anaemia in major cancer surgery-service evaluation [abstract]. Tranfus Med 2013; 23 Suppl 1: 38 [DOI: 10.1111/tme.12023]
69. Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846-853. e1-2 [PMID: 21699794 DOI: 10.1053/j.gastro.2011.06.005]
70. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int 2003; 64: 572-578 [PMID: 12846752 DOI: 10.1046/j.1523-1755.2003.00099.x]
71. Pagani A, Nai A, Corna G, Bosurgi L, Rovere-Querini P, Camaschella C, Silvestri L. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 2011; 118: 736-746 [PMID: 21628413 DOI: 10.1182/ blood-2011-02-337212]
72. Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis 2009; 16: 143-151 [PMID: 19233073 DOI: 10.1053/j.ackd.2008.12.008]
73. Barton JC, Barton EH, Bertoli LF, Gothard CH, Sherrer JS. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. Am J Med 2000; 109: 27-32 [PMID: 10936475]
74. Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996; 28: 529-534 [PMID: 8840942]
75. Braga M, Gianotti L, Gentilini O, Vignali A, Corizia L, Di Carlo V. Erythropoiesis after therapy with recombinant human erythropoietin: a dose-response study in anemic cancer surgery patients. Vox Sang 1999; 76: 38-42 [PMID: 9933852]
76. Kettelhack C, Hönes C, Messinger D, Schlag PM. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998; 85: 63-67 [PMID: 9462386]
77. Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery--prospective double-blind placebo-controlled study. World J Surg 1999; 23: 30-35 [PMID: 9841760]
78. Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G. Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg 2003; 237: 417-421 [PMID: 12616127]
79. Christodoulakis M, Tsiftsis DD, Hellenic Surgical Oncology Perioperative EPO Study Group. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study. Ann Surg Oncol 2005; 12: 718-725 [PMID: 16052276]
80. Norager CB, Jensen MB, Madsen MR, Qvist N, Laurberg S. Effect of darbepoetin alfa on physical function in patients undergoing surgery for colorectal cancer. A randomized, double-blind, placebo-controlled study. Oncology 2006; 71: 212-220 [PMID: 17641543 DOI: 10.1159/000106071]
81. Glaspy J, Crawford J, Vansteenkiste J, Henry D, Rao S, Bowers P, Berlin JA, Tomita D, Bridges K, Ludwig H. Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer 2010; 102: 301-315 [PMID: 20051958 DOI: 10.1038/ sj.bjc.6605498]
82. Beguin Y. Erythropoietin and platelet production. Haematologica 1999; 84: 541-547 [PMID: 10366799]
83. Henry DH, Dahl NV, Auerbach MA. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron. Am J Hematol 2012; 87: 308-310 [PMID: 22262486 DOI: 10.1002/ajh.22262]
84. Aapro MS, Link H. September 2007 update on EORTC guidelines and anemia management with erythropoiesisstimulating agents. Oncologist 2008; 13 Suppl 3: 33-36 [PMID: 18458123 DOI: 10.1634/theoncologist.13-S3-33]
85. National Comprehensive Cancer Network®. NCCN clinical practice guidelines in oncology. Cancer-and chemotherapy-induced anemia. Version 1.2013, August 2012. Available from: URL: http://www.nccn.org Accessed 17 July 2013
86. Mikhael J, Melosky B, Cripps C, Rayson D, Kouroukis CT. Canadian supportive care recommendations for the management of anemia in patients with cancer. Curr Oncol 2007; 14: 209-217 [PMID: 17938704]
87. Bennett CL, Spiegel DM, Macdougall IC, Norris L, Qureshi ZP, Sartor O, Lai SY, Tallman MS, Raisch DW, Smith SW, Silver S, Murday AS, Armitage JO, Goldsmith D. A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 2012; 38: 783-796 [PMID: 23111861 DOI: 10.1055/s-0032-1328884]
88. Devon KM, McLeod RS. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database Syst Rev 2009; (1): CD007148 [PMID: 19160325 DOI: 10.1002/14651858. CD007148.pub2]
89. Burden S, Todd C, Hill J, Lal S. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev 2012; 11: CD008879 [PMID: 23152265 DOI: 10.1002/14651858.CD008879.pub2]
90. Zhuang CL, Ye XZ, Zhang XD, Chen BC, Yu Z. Enhanced recovery after surgery programs versus traditional care for colorectal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum 2013; 56: 667-678 [PMID: 23575408 DOI: 10.1097/DCR.0b013e3182812842]
91. Camus Y, Delva E, Cohen S, Lienhart A. The effects of warming intravenous fluids on intraoperative hypothermia and postoperative shivering during prolonged abdominal surgery. Acta Anaesthesiol Scand 1996; 40: 779-782 [PMID: 8874562]
92. Scott EM, Buckland R. A systematic review of intraoperative warming to prevent postoperative complications. AORN J 2006; 83: 1090-104, 1107-13 [PMID: 16722286]
93. Wong PF, Kumar S, Bohra A, Whetter D, Leaper DJ. Randomized clinical trial of perioperative systemic warming in major elective abdominal surgery. Br J Surg 2007; 94: 421-426 [PMID: 17380549 DOI: 10.1002/bjs.5631]
94. Pu Y, Cen G, Sun J, Gong J, Zhang Y, Zhang M, Wu X, Zhang J, Qiu Z, Fang F. Warming with an underbody warming system reduces intraoperative hypothermia in patients undergoing laparoscopic gastrointestinal surgery: a randomized controlled study. Int J Nurs Stud 2014; 51: 181-189 [PMID: 23787221 DOI: 10.1016/j.ijnurstu.2013.05.013]
95. Bundgaard-Nielsen M, Secher NH, Kehlet H. 'Liberal' vs. 'restrictive' perioperative fluid therapy--a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53: 843-851 [PMID: 19519723 DOI: 10.1111/j.1399-6576.2009.02029.x]
96. Cohn SM, Pearl RG, Acosta SM, Nowlin MU, Hernandez A, Guta C, Michalek JE. A prospective randomized pilot study of near-infrared spectroscopy-directed restricted fluid therapy versus standard fluid therapy in patients undergoing elective colorectal surgery. Am Surg 2010; 76: 1384-1392 [PMID: 21265353]
97. Futier E, Constantin JM, Petit A, Chanques G, Kwiatkowski F, Flamein R, Slim K, Sapin V, Jaber S, Bazin JE. Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: A prospective randomized trial. Arch Surg 2010; 145: 1193-1200 [PMID: 21173294 DOI: 10.1001/archsurg.2010.275]
98. Varadhan KK, Lobo DN. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc 2010; 69: 488-498 [PMID: 20515521 DOI: 10.1017/ S0029665110001734]
99. Yates DR, Davies SJ, Milner HE, Wilson RJ. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth 2014; 112: 281-289 [PMID: 24056586 DOI: 10.1093/bja/aet307]
100. Brar MS, Brar SS, Dixon E. Perioperative supplemental oxygen in colorectal patients: a meta-analysis. J Surg Res 2011; 166: 227-235 [PMID: 19922947 DOI: 10.1016/j.jss.2009.06.007]
101. Auerbach M, Pappadakis JA, Bahrain H, Auerbach SA, Ballard H, Dahl NV. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol 2011; 86: 860-862 [PMID: 21922526 DOI: 10.1002/ajh.22153]
102. Auerbach M, Strauss W, Auerbach S, Rineer S, Bahrain H. Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am J Hematol 2013; 88: 944-947 [PMID: 23828252 DOI: 10.1002/ajh.23534]